DACLATASVIR (NATDAC) TABLET – TREATMENT FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION
An antiviral drug is called Natdac 60 Tablet. It is utilized in conjunction with other drugs to treat chronic hepatitis C virus (HCV) infection.
The dosage and duration of Natdac 60 Tablet should be followed as prescribed by your doctor. It should be taken, preferably at a set time, with or without food. Even if you feel better, do not miss any doses and complete the entire course of treatment. Take the missed dose as soon as you remember.
USES OF DACLATASVIR (NATDAC) TABLET
- Chronic hepatitis C virus (HCV) infection
WORKS OF DACLATASVIR (NATDAC) TABLET
An antiviral drug is called Natdac 60 Tablet. It functions by gradually reducing the amount of the hepatitis C virus in the body and eradicating the infection from the blood.
SIDE EFFECTS OF DACLATASVIR (NATDAC) TABLET
- Insomnia (difficulty in sleeping)
- Anemia (low number of red blood cells)
WARNING & PRECAUTIONS
The ability to drive may be affected by Natdac 60 Tablet, however, this is unknown. If you encounter any symptoms that impair your focus or reaction time, avoid operating a vehicle.
Patients with kidney conditions can use Natdac 60 Tablet without risk. Natdac 60 Tablet should not have its dosage changed.
Patients with liver conditions can use Natdac 60 Tablet without risk. Natdac 60 Tablet should not have its dosage changed.
Fedelty Health Care is a Daclatasvir third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.